125 related articles for article (PubMed ID: 8962138)
1. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.
Lorimer IA; Keppler-Hafkemeyer A; Beers RA; Pegram CN; Bigner DD; Pastan I
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14815-20. PubMed ID: 8962138
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.
Chowdhury PS; Viner JL; Beers R; Pastan I
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):669-74. PubMed ID: 9435250
[TBL] [Abstract][Full Text] [Related]
3. Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
Archer GE; Sampson JH; Lorimer IA; McLendon RE; Kuan CT; Friedman AH; Friedman HS; Pastan IH; Bigner DD
Clin Cancer Res; 1999 Sep; 5(9):2646-52. PubMed ID: 10499644
[TBL] [Abstract][Full Text] [Related]
4. Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.
Chandramohan V; Bao X; Keir ST; Pegram CN; Szafranski SE; Piao H; Wikstrand CJ; McLendon RE; Kuan CT; Pastan IH; Bigner DD
Clin Cancer Res; 2013 Sep; 19(17):4717-27. PubMed ID: 23857604
[TBL] [Abstract][Full Text] [Related]
5. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
Kuan CT; Wikstrand CJ; Archer G; Beers R; Pastan I; Zalutsky MR; Bigner DD
Int J Cancer; 2000 Dec; 88(6):962-9. PubMed ID: 11093822
[TBL] [Abstract][Full Text] [Related]
6. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.
Kioi M; Seetharam S; Puri RK
Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228
[TBL] [Abstract][Full Text] [Related]
7. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
[TBL] [Abstract][Full Text] [Related]
8. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression.
Meng J; Liu Y; Gao S; Lin S; Gu X; Pomper MG; Wang PC; Shan L
Cancer Biol Ther; 2015; 16(12):1764-74. PubMed ID: 26467217
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.
Lorimer IA; Wikstrand CJ; Batra SK; Bigner DD; Pastan I
Clin Cancer Res; 1995 Aug; 1(8):859-64. PubMed ID: 9816055
[TBL] [Abstract][Full Text] [Related]
10. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
11. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
12. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display.
Beers R; Chowdhury P; Bigner D; Pastan I
Clin Cancer Res; 2000 Jul; 6(7):2835-43. PubMed ID: 10914732
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers.
Rahbarnia L; Farajnia S; Babaei H; Majidi J; Dariushnejad H; Hosseini MK
Immunol Lett; 2016 Dec; 180():31-38. PubMed ID: 27984065
[TBL] [Abstract][Full Text] [Related]
15. Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.
Schmidt M; Reiser P; Hills D; Gullick WJ; Wels W
Int J Cancer; 1998 Mar; 75(6):878-84. PubMed ID: 9506533
[TBL] [Abstract][Full Text] [Related]
16. Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.
Kuan CT; Wakiya K; Keir ST; Li J; Herndon JE; Pastan I; Bigner DD
Int J Cancer; 2011 Jul; 129(1):111-21. PubMed ID: 20824708
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology.
Rahbarnia L; Farajnia S; Babaei H; Majidi J; Akbari B; Ahdi Khosroshahi S
Adv Pharm Bull; 2016 Dec; 6(4):563-571. PubMed ID: 28101463
[No Abstract] [Full Text] [Related]
19. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
[TBL] [Abstract][Full Text] [Related]
20. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
Piao H; Kuan CT; Chandramohan V; Keir ST; Pegram CN; Bao X; Månsson JE; Pastan IH; Bigner DD
MAbs; 2013; 5(5):748-62. PubMed ID: 23924792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
